Iranian Blood transfusion organization has implemented a mandatory haemovigilance system to monitor Adverse Transfusion Events (ATEs) since 2009.
The scope of Iranian Haemovigilance System (IHS) encompasses all blood components issued by blood transfusion centers, all adverse reactions and all hospitals (public and private hospitals).
After preparing the standard forms, slides, different guidelines and SOPs, all health care staff including nurses and doctors as well as the staff of hospital blood banks have been trained to identify and manage all adverse reactions of blood transfusion. From January 2009 to 2016, this system was established in 612 (73%) hospitals (from 863 hospitals across the country). Hospitals use uniform forms for blood requests; monitor patients during blood administration and report all adverse reactions.
We aimed to gather and analyze transfusion reactions to help prevent their occurrence and/or reoccurrence.
- IBTO's representatives participate in Governing Council meeting of AATM in New Delhi
- IBTO in collaboration with WHO EMRO to prepare the 15-year trend of blood safety and availability in the region
- IRETM's student wins the Best Research Poster Presentation Award in AABB-AATM 2018 joint congress
- IBTO's representative shares Iran's experience in the 2nd National Transfusion Medicine Workshop in Muscat
- AATM-AABB 2018 joint Congress: Blood safety in Iran comparable to developed countries
- IBTO Joins Worldwide search for planet's rarest blood type for 2-year-old
- Tehran Times: HIV risk from blood transfusion cut to zero in 16 provinces
- IBTO in collaboration with WHO-EMRO to prepare 15-year regional status report for blood safety and availability in EMR
- The Governing Council Meeting of Asian Association of Transfusion Medicine in Tehran
- International workshop on Strengthening Leadership and Governance of National Blood Services